Daiichi Sankyo ADC-arkiv - Biosector Ltd.

Stefan speaking on stage at a pharmaceutical industry conference, in front of a large presentation screen about Daiichi Sankyo, antibody-drug conjugates, and new business opportunities in oncology.

by Stefan Sandström

August 10, 2026

Daiichi Sankyo ADC strategy: Where Your New Opportunities Lie

Daiichi Sankyo has built one of the pharmaceutical industry’s most productive antibody-drug conjugate platforms. Enhertu has […]

0